4-Substituted-6-phenylpyrimidine derivatives containing ureido moieties and their preparation methods and uses
A technology of phenylpyrimidine and derivatives, applied in the field of medicinal chemical synthesis, can solve problems such as difficulty in meeting the needs of patients
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0013] Example 12-((4-chloro-6-phenylpyrimidin-2-yl)thio)-N-(pyridyl-2-carbamoyl)acetamide
[0014] At 50°C, 6-phenyl-2-thiouracil (2.04g, 10.0mmol) was dissolved in 30ml of potassium hydroxide (0.4g, 10.0mmol) in aqueous solution, and then 2-chloro-N-(pyridine Base-2-carbamoyl) acetone solution (20ml) of acetamide (2.13g, 10.0mmol) was added dropwise to the reaction solution, continued to react for half an hour after the dropwise addition, filtered with suction, washed the filter cake with water and washed three times with acetone ( 3×10ml) to obtain pure 2-((4-hydroxy-6-phenylpyrimidin-2-yl)thio)-N-(pyridyl-2-carbamoyl)acetamide.
[0015] At 0°C, slowly add 10ml of thionyl chloride to the 2-((4-hydroxy-6-phenylpyrimidin-2-yl)thio)-N-(pyridyl-2-carbamoyl) synthesized above In acetamide (1.91g, 5.0mmol), after the addition, the temperature was slowly raised to 90°C, the reaction was continued for 1 hour, and then the reaction was stopped. After the reaction solution was coole...
Embodiment 2
[0017] Example 22-((4-((4-methylphenyl)amino)-6-phenylpyrimidin-2-yl)thio)-N-(pyridyl-2-carbamoyl)acetamide
[0018] The 2-((4-chloro-6-phenylpyrimidin-2-yl)sulfur)-N-(pyridyl-2-carbamoyl)acetamide (120.02mg, 0.3mmol) and p-methyl Aniline (38.57mg, 0.36mmol) was added to 5ml of glacial acetic acid, and then the temperature was raised to 90°C. After the reaction was detected by TLC, the reaction was stopped. Suction filtration while it was hot, and the filter cake was washed with glacial acetic acid (3×10ml).
[0019] White solid powder, yield 70.3%; 1 HNMR (400MHz, DMSO-d 6 ,δ,ppm):11.28(s,1H),10.77(s,1H),9.83(s,1H),8.28(d,J=4.8Hz,1H),8.00(dd,J=7.7,1.7Hz, 3H),7.83(t,J=7.8Hz,1H),7.66(d,J=8.0Hz,2H),7.48(dd,J=12.5,6.8Hz,3H),7.36(t,J=7.9Hz, 2H),7.16–7.10(m,1H),7.05(t,J=7.4Hz,1H),6.99(s,1H),4.20(s,2H). 13 CNMR (100MHz, DMSO-d 6 ,δ,ppm):171.70(s),169.56(s),161.58(s),161.20(s),151.17(s),150.89(s),148.30(s),139.87(s),139.36(s) ,136.81(s),131.01(s),129.29(d,J=2.4Hz),126.94(s),12...
Embodiment 3
[0020] Example 32-((4-((4-methoxyphenyl)amino)-6-phenylpyrimidin-2-yl)thio)-N-(pyridyl-2-carbamoyl)acetamide
[0021] In the method of Example 2, p-methylaniline is replaced with p-methoxyaniline and obtained.
[0022] White solid powder, yield 84.5%; 1 HNMR (400MHz, DMSO-d 6 ,δ,ppm):11.25(s,1H),10.77(s,1H),9.68(s,1H),8.28(d,J=4.5Hz,1H),7.98(t,J=7.3Hz,3H) ,7.83(t,J=7.8Hz,1H),7.52(d,J=8.6Hz,2H),7.47(t,J=6.3Hz,3H),7.16–7.10(m,1H),6.94(d, J=8.9Hz,2H),6.89(s,1H),4.18(s,2H),3.73(s,3H). 13 CNMR (100MHz, DMSO-d 6 ,δ,ppm):171.66(s),169.48(s),161.24(s),155.76(s),151.18(s),150.90(s),148.32(s),139.33(s),136.80(s) ,132.61(s),130.93(s),129.25(s),126.93(s),122.55(s),120.12(s),114.53(s),113.65(s),98.45(s),55.61(s) ,35.88(s).HR-MS(ESI) CalcdforC 25 h 22 N 6 o 3 S[M+H] + :487.1552,found:487.1551..
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 